BindingDB logo
myBDB logout

56 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27004954 8 Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs.EBI Donghua University
25699147 6 Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.EBI Uppsala University
19013821 12 Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.EBI Punjabi University
18158200 10 Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.EBI Punjabi University
20073471 15 Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.EBI The University of Mississippi
18318468 39 Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.EBI Universit£ di Siena
16220978 14 Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.EBI Uppsala University
11960488 3 Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.EBI Uppsala University
8410980 9 2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.EBI Abbott Laboratories
1469703 14 Dihydropyrimidine angiotensin II receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
 17 1,4-substituted indoles: a potent and selective class of angiostensin II receptor antagonistsEBI TBA
 8 Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonistsEBI TBA
 54 4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridines: potent arylacetic acid-derived AT1 antagonists with improved affinity for the AT2 receptorEBI TBA
 42 Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureasEBI TBA
 31 Uracil-based angiotensin II receptor antagonistsEBI TBA
 60 The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptorsEBI TBA
 56 Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypesEBI TBA
 24 Discovery of nonpeptide potent conformationally restricted angiotensin II receptor antagonistsEBI TBA
 134 Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.EBI TBA
 46 Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinitiesEBI TBA
 12 A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonistEBI TBA
 1 Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonistsEBI TBA
 12 Quinoline-4-carboxylic acids as angiotensin II receptor antagonistsEBI TBA
 16 Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activityEBI TBA
 6 Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonistsEBI TBA
 19 Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamideEBI TBA
18599297 50 Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.EBI Uppsala University
17825570 32 Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.EBI Uppsala University
15115399 41 Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.EBI Università di Siena
12643919 50 Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
12190306 14 Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
10579820 4 Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT(1) receptor.EBI Laboratoires Fournier S.A.
8510101 37 Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.EBI Warner-Lambert Company
8496939 100 Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.EBI Merck Research Laboratories
8421274 27 Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.EBI Searle & Company
8340920 43 Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists.EBI Searle R&D
8258826 42 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.EBI Dr. Karl Thomae GmbH
8230127 52 A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.EBI Sanofi Recherche
8201597 10 Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.EBI E. Merck
8057285 44 Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists.EBI Carpibem
2362273 1 Conformational restriction of angiotensin II: cyclic analogues having high potency.EBI G. D. Searle and Company
1920360 13 Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.EBI Ciba Geigy Limited
1635064 8 Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.EBI Lilly Research Laboratories
1433195 15 Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.EBI SmithKline Beecham Pharmaceuticals
1433184 18 Discovery of a novel class of orally active, non-peptide angiotensin II antagonists.EBI Abbott Laboratories
15831442 46 Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.BDB Taisho Pharmaceutical Co., Ltd
12721338 61 N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.BDB Pudue Pharma Discovery Research
12570021 16 Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.BDB Shinshu University
11082453 77 ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.BDB Abbott Laboratories
7891350 9 Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.BDB Parke-Davis Pharmaceutical Research